{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n(10) as disclosed it binds to IL-22 with a dissociation constant of 500 nM or less;\n(11) as disclosed it binds to IL-22 with a dissociation constant of 10 nM or less;\n(12) as disclosed it binds to IL-22 with a dissociation constant of 150 pM or less;\n(13) as disclosed it binds to IL-22 with a dissociation constant of 60 pM or less;\n(14) according to the invention it inhibits binding of IL-22 to IL-22R or a receptor complex of IL-22R and IL-10R2 with an IC50 of 10 nM or less;\n(15) according to the invention it blocks IL-22 mediated proliferation of IL-22 receptor engineered BaF3 cells with an IC50 of 1 nM or less in one embodiment, with an IC50 of 150 pM or less in another embodiment, as disclosed with an IC50 of 100 pM or less, and as disclosed with an IC50 of 10 pM or;\n(16) as disclosed it blocks IL-22 mediated GROa secretion from HT29 cells with an IC50 of 1 nM or less in one disclosure, with an IC50 of 150 pM or less in another disclosure, and with an IC50 of 10 pM or less in another disclosure."}
{"final_json": [{"molecule_name": null, "protein_target_name": "IL-22", "binding_metric": "Kd", "value": "500", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "IL-22", "binding_metric": "Kd", "value": "10", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "IL-22", "binding_metric": "Kd", "value": "150", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-22", "binding_metric": "Kd", "value": "60", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-22R or a receptor complex of IL-22R and IL-10R2", "binding_metric": "IC50", "value": "10", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "IL-22 receptor", "binding_metric": "IC50", "value": "1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "IL-22 receptor", "binding_metric": "IC50", "value": "150", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-22 receptor", "binding_metric": "IC50", "value": "100", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-22 receptor", "binding_metric": "IC50", "value": "10", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-22", "binding_metric": "IC50", "value": "1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "IL-22", "binding_metric": "IC50", "value": "150", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-22", "binding_metric": "IC50", "value": "10", "unit": "pM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* it binds to IL-22 with a dissociation constant of 500 nM or less;\n* it binds to IL-22 with a dissociation constant of 10 nM or less;\n* it binds to IL-22 with a dissociation constant of 150 pM or less;\n* it binds to IL-22 with a dissociation constant of 60 pM or less;\n* it inhibits binding of IL-22 to IL-22R or a receptor complex of IL-22R and IL-10R2 with an IC50 of 10 nM or less;\n* it blocks IL-22 mediated proliferation of IL-22 receptor engineered BaF3 cells with an IC50 of 1 nM or less in one embodiment, with an IC50 of 150 pM or less in . another disclosure, with an IC50 of 100 pM or less in another disclosure, and with an IC50 of 10 pM or less in another disclosure;\n* it blocks IL-22 mediated GROa secretion from HT29 with an IC50 of 1 nM or less in one disclosure, with an IC50 of 150 pM or less in another disclosure, and with an IC50 of 10 pM or less in another disclosure."}
{"final_json": [{"molecule_name": null, "protein_target_name": "IL-22", "binding_metric": "Kd", "value": "<500", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "IL-22", "binding_metric": "Kd", "value": "<10", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "IL-22", "binding_metric": "Kd", "value": "<150", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-22", "binding_metric": "Kd", "value": "<60", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-22R or IL-22R and IL-10R2", "binding_metric": "IC50", "value": "<10", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "IL-22 receptor", "binding_metric": "IC50", "value": "<1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "IL-22 receptor", "binding_metric": "IC50", "value": "<150", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-22 receptor", "binding_metric": "IC50", "value": "<100", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-22 receptor", "binding_metric": "IC50", "value": "<10", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-22", "binding_metric": "IC50", "value": "<1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "IL-22", "binding_metric": "IC50", "value": "<150", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-22", "binding_metric": "IC50", "value": "<10", "unit": "pM"}]}
{"raw_mentions": "There are no sentences in the provided text that contain all four required components: a specific molecule name, ID or other identifier, a bioactivity metric (IC50, Ki, Kd, EC50 and their variations), a specific numeric value for that metric, and a unit for that value."}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTable 11B. Kinetic data of rat monoclonal antibodies for human IL-22: Ab-022.78 E+051.45 E-031.92 E+085.22 E-080.49\nTable 11B. Kinetic data of rat monoclonal antibodies for human IL-22: Ab-045.15 E+051.23 E-034.22 E+082.38E-090.53\nTable 12. Kinetic data of human monoclonal antibodies for human IL-22: 356A117.91 E+044.27 E-061.85 E+105.40 E-110.223\nTable 12. Kinetic data of human monoclonal antibodies for human IL-22: 368D041.89 E+052.50 E-057.56 E+091.32 E-100.298\nSpecifically, the dissociation constant of 356A11 (K<sub>D</sub>=5.40 x 10<sup>-11</sup> M or 0.054 nM) for human IL-22 is approximately 1000-fold and more than 40-fold greater than the dissociation constants of Ab-02 (K<sub>D</sub> = 5.22 x 10<sup>-8</sup> M or 52 nM) and Ab-04 (K<sub>D</sub> = 2.38 x 10<sup>-9</sup> M or 2.38 nM), respectively.\nSimilarly, 368D04 (K<sub>D</sub> = 1.32 x 10<sup>-10</sup> M or 0.132 nM) has an approximately 400-fold and 18-fold stronger affinity for human IL-22 than Ab-02 and Ab-04, respectively."}
{"final_json": [{"molecule_name": "Ab-022", "protein_target_name": "human IL-22", "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "Ab-045", "protein_target_name": "human IL-22", "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "356A117", "protein_target_name": "human IL-22", "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "368D041", "protein_target_name": "human IL-22", "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "356A11", "protein_target_name": "human IL-22", "binding_metric": "Kd", "value": "5.40 x 10^-11", "unit": "M"}, {"molecule_name": "356A11", "protein_target_name": "human IL-22", "binding_metric": "Kd", "value": "0.054", "unit": "nM"}, {"molecule_name": "Ab-02", "protein_target_name": "human IL-22", "binding_metric": "Kd", "value": "5.22 x 10^-8", "unit": "M"}, {"molecule_name": "Ab-02", "protein_target_name": "human IL-22", "binding_metric": "Kd", "value": "52", "unit": "nM"}, {"molecule_name": "Ab-04", "protein_target_name": "human IL-22", "binding_metric": "Kd", "value": "2.38 x 10^-9", "unit": "M"}, {"molecule_name": "Ab-04", "protein_target_name": "human IL-22", "binding_metric": "Kd", "value": "2.38", "unit": "nM"}, {"molecule_name": "368D04", "protein_target_name": "human IL-22", "binding_metric": "Kd", "value": "1.32 x 10^-10", "unit": "M"}, {"molecule_name": "368D04", "protein_target_name": "human IL-22", "binding_metric": "Kd", "value": "0.132", "unit": "nM"}]}
